BUDGET IMPACT ANALYSIS OF ALEMTUZUMAB IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS IN HEALTHCARE SOCIAL SECURITY (ESSALUD) IN PERU

被引：0
|
作者：
Moreno, M. [1 ]
Arce, J. [1 ]
Cruz, A. [2 ]
Carpio Farro, R. [3 ]
机构：
[1] Sanofi Aventis Colombia, Bogota, Cun, Colombia
[2] Hosp Alberto Sabogal, Magdalena Del Mar, Peru
[3] Sanofi Aventis Peru, Lima, Peru
来源：
VALUE IN HEALTH | 2020年 / 23卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PND37
引用
收藏
页码：S265 / S265
页数：1
相关论文
共 50 条
  • [1] ALEMTUZUMAB BUDGET IMPACT ANALYSIS IN RELAPSING-REMITTING MULTIPLE SCLEROSIS IN THE US
    Celestin, C.
    Wandstrat, T.
    Coleman, C., I
    [J]. VALUE IN HEALTH, 2015, 18 (03) : A280 - A280
  • [2] BUDGET IMPACT MODELLING FOR ALEMTUZUMAB IN RELAPSING-REMITTING MULTIPLE SCLEROSIS PATIENTS IN COLOMBIA
    Londono, S.
    Gomez, N.
    [J]. VALUE IN HEALTH, 2020, 23 : S625 - S625
  • [3] Alemtuzumab in the treatment of relapsing-remitting multiple sclerosis
    Fox, Edward J.
    [J]. EXPERT REVIEW OF NEUROTHERAPEUTICS, 2010, 10 (12) : 1789 - 1797
  • [4] Alemtuzumab for the treatment of relapsing-remitting multiple sclerosis
    Hersh, Carrie M.
    Cohen, Jeffrey A.
    [J]. IMMUNOTHERAPY, 2014, 6 (03) : 249 - 259
  • [5] Autoimmunity in patients treated with alemtuzumab for relapsing-remitting multiple sclerosis
    Fox, E. J.
    Arnold, D. L.
    Cohen, J.
    Coles, A. J.
    Confavreux, C.
    Hartung, H. -P.
    Havrdova, E.
    Selmaj, K.
    Weiner, H.
    Lake, S. L.
    Margolin, D. H.
    Oyuela, P.
    Panzara, M.
    Compston, D. A. S.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 465 - 466
  • [6] BUDGET IMPACT ANALYSIS OF CLADRIBINE TABLETS FOR TREATMENT OF PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS IN BULGARIA
    Djambazov, S.
    Slavchev, G.
    Dineva, T.
    Panayotov, P.
    Vekov, T.
    [J]. VALUE IN HEALTH, 2018, 21 : S205 - S205
  • [7] Alemtuzumab improves contrast sensitivity in patients with relapsing-remitting multiple sclerosis
    Graves, Jennifer
    Galetta, Steven L.
    Palmer, Jeffrey
    Margolin, David H.
    Rizzo, Marco
    Bilbruck, John
    Balcer, Laura J.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (10) : 1302 - 1309
  • [8] The use of alemtuzumab in patients with relapsing-remitting multiple sclerosis: the Gulf perspective
    Alroughani, Raed
    Van Wijmeersch, Bart
    Al Khaboori, Jabber
    Alsharoqi, Isa Ahmed
    Ahmed, Samar F.
    Hassan, Ali
    Inshasi, Jihad
    Krieger, Derk W.
    Shakra, Mustafa
    Shatila, Ahmed Osman
    Szolics, Miklos
    Khallaf, Mohamed
    Ezzat, Aly
    [J]. THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2020, 13
  • [9] Effect of alemtuzumab on quality of life in patients with relapsing-remitting multiple sclerosis
    Bass, Ann
    [J]. MULTIPLE SCLEROSIS, 2009, 15 (11): : 1396 - 1396
  • [10] Alemtuzumab Improves Contrast Sensitivity in Relapsing-Remitting Multiple Sclerosis Patients
    Balcer, Laura
    Galetta, Steven
    Maguire, Maureen
    Palmer, Jeffrey
    Margolin, David
    Rizzo, Marco
    [J]. NEUROLOGY, 2011, 76 (09) : A446 - A446
12345